Informatics

Whitepaper: Opportunities in preclinical development

11 July 2018 | By IDBS

This whitepaper explains how you can find ways to optimise the holistic preclinical development process...

MedImmune expert speaker interview released in run up to Immuno-Oncology Conference

10 July 2018 | By SMi Group

Exclusive interview with Grace Macaulay - MedImmune released in the run up to the Immuno-Oncology Conference, taking place on the 26 - 27 September 2018 in London.

New software designed for rapid, automated identification of dendritic spines

6 July 2018 | By Drug Target Review

Researchers release open source software, connecting and building the neuroscience coding community...

Algorithm used to map cancer resistance to drugs

5 July 2018 | By Drug Target Review

New methods of studying the evolution of treatment resistance in head and neck cancer are being developed by researchers at the Johns Hopkins Kimmel Cancer Center...

New biomarker provides personalised treatment options for bladder cancer

2 July 2018 | By Drug Target Review

Researchers use data science and genomics to help determine best treatment options for specific bladder cancers...

Researchers apply computing power to track the spread of cancer

2 July 2018 | By Drug Target Review

Researchers have developed a new computational method that increases the ability to track the spread of cancer cells from one part of the body to another...

Application note: Analyte quarterly Vol 1

29 June 2018 | By Merck KGaA

Your comprehensive guide to multiplex and single protein detection...

Application note: Real-time detection of Gs and Gi Signalling in living cells

20 June 2018 | By BMG Labtech GmbH

Genetically-encoded biosensors from Montana Molecular allow for detection of GPCR signalling...

Expert view: Rising growth of the global high‑content screening software and services market

11 June 2018 | By Jeff McMillan (Senior Product Manager Imaging at Molecular Devices)

The global high-content screening (HCS) software and services market accounted for over $500 million in 2017 and is expected to reach approximately $1.4 billion by 2026, increasing at a compound annual growth rate of more than 11%, says Jeff McMillan, Senior Product Manager Imaging, Molecular Devices.

Transforming translational research: CANscript^TM – a better predictive model for oncology

8 June 2018 | By Mark Paris

This webinar focused on a recent study evaluating a cohort of head and neck squamous cell carcinoma (HNSCC) patient tumours treated with anti-PD1 using CANscript™.

Tecan

BD

Tau mutations may increase cancer risk

25 May 2018 | By Dr Zara Kassam (Drug Target Review)

Mutations in the protein tau, commonly associated with neurodegenerative disorders, may serve as a novel risk factor for cancer...

Scientists reveal model that estimates lifetime risk of developing Alzheimer’s dementia

23 May 2018 | By Drug Target Review

The Alzheimer’s Association have published a study wherein a model estimates the lifetime risk of an individual developing Alzheimer’s disease dementia. The risk varies with such factors as age and gender, and crucially takes account of preclinical biological changes.

Lab-on-a-chip device mimics eye damage due to intense light

11 May 2018 | By Dr Zara Kassam (Drug Target Review)

Researchers create eye neuron network model to study retinal diseases, possible treatment options...